Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.21 +0.06 (+2.79%)
At close: Aug 21, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Amortizatization of Intangibles (2021)

Black Diamond Therapeutics' (BDTX) quarterly Amortizatization of Intangibles came in at $720000.0 in Q1 2021.

Black Diamond Therapeutics (BDTX) Amortizatization of Intangibles (2021) Analysis & Trends

Black Diamond Therapeutics (BDTX) has 1 years of Amortizatization of Intangibles data on file, last reported at $720000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Black Diamond Therapeutics 125.92 Mn 15.42 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 720,000.00
Mar 31, 2021 720,000.00